About this trial
Despite international efforts to identify biomarkers of depression, none has been transferred to clinical practice, neither for diagnosis, evolution, nor therapeutic response. This led us to build a French national cohort (through the clinical and research network named SoPsy within the French biological psychiatry society (AFPBN) and sleep society (SFRMS)), to better identify markers of sleep and biological rhythms and validate more homogeneous subgroups of patients, but also to specify the manifestations and pathogeneses of depressive disorders.
Eligibility criteria
Qualifiers
Individuals with depressive episode characterized according to the DSM-5 criteria regardless of the associated characteristics and comorbidities.
Adult and child
Affiliated to a social security
Disqualifiers
don't understand or read french
Medical condition incompatible with administration of questionnaire
impossibility to give informed decision (subject in an emergency condition, etc.)
Trial design
Treatments tested in this trial
- Not listed